Aclaris Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.97 |
Market Cap |
$97.4 M |
Shares Outstanding |
41.27 M |
Public Float |
33.85 M |
Address |
640 Lee Road Malvern Pennsylvania 19087 United States |
Employees | - |
Website | http://www.aclaristx.com |
Updated | 07/08/2019 |
Aclaris Therapeutics, Inc. is a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address unmet needs in medical and aesthetic dermatology and immunology. It operates thrpough Dermatology Therapeutics and Contract Research segments. The Dermatology Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. |